What Are GLP-1 Agonists? A Guide to Ozempic, Mounjaro & More
You’ve probably heard the names. Ozempic. Trulicity. Mounjaro. These medications have become household names, transforming the way we treat both type 2 diabetes and obesity.
But what are they, exactly? All of these popular drugs belong to a powerful class of medications called GLP-1 agonists.
So, what are GLP-1 agonists, and how do they work their magic? Let’s break down the science behind these game-changing medications.
What Are GLP-1 Agonists in Simple Terms?
GLP-1 agonists (also known as GLP-1 receptor agonists or incretin mimetics) are a class of medications that primarily help manage blood sugar levels in people with type 2 diabetes. Some of them are also approved to help treat obesity.
Most of these medications are injectables that you give yourself just under the skin (a subcutaneous injection) in your belly, thigh, or the back of your arm. However, there is also a pill form available.
It’s crucial to understand that these medications are not a standalone cure. They are designed to be one part of a comprehensive treatment plan that includes lifestyle and dietary changes.
How Do GLP-1 Agonists Work?
The secret to how these drugs work lies in a naturally occurring hormone in our bodies called GLP-1.
Your small intestine makes this hormone when you eat. It plays several key roles:
- It triggers insulin release: This is the big one. It signals your pancreas to release insulin, which helps lower the sugar in your blood.
- It blocks glucagon: It stops another hormone, glucagon, from raising your blood sugar levels.
- It slows down your stomach: It slows how quickly your stomach empties, which means sugar from your food is released more slowly into your bloodstream.
- It makes you feel full: It affects the parts of your brain that control hunger, increasing your feeling of satiety.
GLP-1 agonist medications work by mimicking this natural hormone. They bind to the same receptors in your body and trigger all of those same powerful effects. The higher the dose, the more pronounced the effects. This is what makes them so effective for both blood sugar control and weight loss.
The List of GLP-1 Agonist Medications
There are several of these medications currently available in the U.S. market.
Weekly Injections:
- Dulaglutide (Trulicity®)
- Exenatide extended-release (Bydureon®)
- Semaglutide injection (Ozempic®)
Daily Injections:
- Exenatide (Byetta®)
- Liraglutide (Victoza®)
- Lixisenatide (Adlyxin®)
Daily Pill:
- Semaglutide tablets (Rybelsus®)
There is also a similar class of dual-agonist medications that mimic both GLP-1 and another hormone called GIP. The one currently on the market is tirzepatide (Mounjaro®), which is also a weekly injection.
Who Are These Medications For?
Healthcare providers prescribe GLP-1 agonists for two main conditions.
1. GLP-1 Agonists for Type 2 Diabetes
These medications are FDA-approved to help manage blood sugar levels in people with type 2 diabetes. Your doctor might recommend one if other medications, like metformin, aren’t working well enough on their own.
2. GLP-1 Agonists for Obesity
Because of their powerful effect on appetite and fullness, certain GLP-1 agonists for weight loss have been FDA-approved. These include semaglutide (sold under the brand name Wegovy) and high-dose liraglutide (Saxenda). The new dual-agonist, tirzepatide, is also approved for weight loss under the brand name Zepbound.
Understanding the Side Effects and Risks
Like any medication, GLP-1 agonists come with potential side effects.
- Most Common Side Effects: These are usually gastrointestinal issues like loss of appetite, nausea, vomiting, and diarrhea. They are most likely to happen when you first start the medication or when you increase your dose.
- Severe (but Rare) Side Effects: In rare cases, more severe side effects can occur, including pancreatitis (inflammation of the pancreas) and acute kidney injury.
It’s also important to know that these medications are generally not considered safe to take during pregnancy. There is also a low risk of hypoglycemia (low blood sugar), especially if you are taking them with other diabetes medications like insulin.
Conclusion
GLP-1 agonists represent a major breakthrough in the treatment of both type 2 diabetes and obesity. By mimicking the body’s own natural hormones, they offer a powerful way to manage blood sugar and support significant weight loss.
However, they are serious prescription medications that require medical supervision. They are not a replacement for a healthy lifestyle but rather a powerful tool to be used alongside it. If you are struggling with type 2 diabetes or obesity, have a conversation with your healthcare provider to see if a GLP-1 agonist might be the right choice for you.
FAQ
What is the main function of GLP-1 agonists?
They mimic a natural hormone, GLP-1, to help lower blood sugar levels by stimulating insulin release and to promote weight loss by increasing feelings of fullness and slowing digestion.
Are all GLP-1 agonists injections?
Most are, but there is one oral (pill) version available called Rybelsus (semaglutide).
What is the difference between Ozempic and Mounjaro?
Ozempic (semaglutide) is a single-agonist that mimics the GLP-1 hormone. Mounjaro (tirzepatide) is a dual-agonist that mimics both the GLP-1 and GIP hormones, which can make it even more effective.
Related Articles
Ozempic Alternative: Guide Other Weight Loss, Diabete Drug
How Metformin Causes Weight Loss: The “Anti-Hunger” Molecule
What is Tirzepatide? A Guide to Mounjaro and Zepbound
Safe Weight Loss Medications: Guide to 5 FDA-Approved Option